These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 61905)

  • 1. Autoimmune reaction to a liver specific membrane antigen during acute viral hepatitis.
    Cochrane AM; Moussouros A; Smith A; Thomson AD; Eddleston AL; Williams R
    Gut; 1976 Sep; 17(9):714-8. PubMed ID: 61905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.
    Cochrane AM; Moussouros A; Thomsom AD; Eddleston AL; Wiiliams R
    Lancet; 1976 Feb; 1(7957):441-4. PubMed ID: 55716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of postacute viral hepatitis: the role of HBsAg.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1986; 24(1):19-22. PubMed ID: 3704499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.
    Alberti A; Realdi G; Bortolotti F; Rigoli AM
    Gut; 1977 Dec; 18(12):1004-9. PubMed ID: 304824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
    Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.
    Mieli-Vergani G; Vergani D; Portmann B; White Y; Murray-Lyon I; Marigold JH; Woolf I; Eddleston AL; Williams R
    Gut; 1982 Dec; 23(12):1029-36. PubMed ID: 6983473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T and B lymphocytes in the liver and peripheral blood of subjects with acute and chronic hepatitis.
    D'Amelio R; Ciarla MV; Pandolfi F; Panichi G; Sposito M; Aiuti F
    Z Immunitatsforsch Immunobiol; 1979 Mar; 155(4):338-45. PubMed ID: 313635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver membrane autoantibodies: methods for their detection and clinical significance.
    Nagai S; Manns M; Meyer zum Büschenfelde KH
    Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behaviour of T and B lymphocytes during the acute phase of viral hepatitis with positive or negative HBsAg.
    Boroń P; Bobrowska E; Boroń-Kaczmarska A; Nadowska K; Szpakowicz T
    Med Interne; 1981; 19(1):79-82. PubMed ID: 6972080
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of active chronic hepatitis.
    Williams R; Eddleston AL
    Ann Acad Med Singap; 1980 Apr; 9(2):158-66. PubMed ID: 6448563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease.
    Cochrane AM; Moussouros A; Portmann B; McFarlane IG; Thomson AD; Eddleston ; Williams R
    Gastroenterology; 1977 May; 72(5 Pt 1):918-23. PubMed ID: 300342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.
    Dehoratius RJ; Henderson C; Strickland RG
    Clin Exp Immunol; 1976 Oct; 26(1):21-7. PubMed ID: 1087213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
    Eddleston AL; Williams R
    Lancet; 1974 Dec; 2(7896):1543-5. PubMed ID: 4140983
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis.
    Poralla T; Hütteroth TH; Meyer zum Büschenfelde KH
    Gut; 1984 Feb; 25(2):114-20. PubMed ID: 6420241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic infections. Part II. The effect of acute and chronic hepatitis B antigenaemia on the reaction to antibodies to sheep red cells (microbial antigens) and human T-activated cells (exposed autologous tissue antigens).
    Vos GH; Vos D; Marimuthu T
    S Afr Med J; 1979 Nov; 56(20):801-4. PubMed ID: 315618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Clin Exp Immunol; 1980 Dec; 42(3):436-40. PubMed ID: 7214740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunopathogenesis of chronic HBV induced liver disease.
    Levy GA; Chisari FV
    Springer Semin Immunopathol; 1981 Apr; 3(4):439-59. PubMed ID: 6168027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.